LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical analysis of genomic data and early cancer diagnostics, today announced a research collaboration with the University of Pittsburgh (Pitt) to advance the preclinical evaluation of Singlera and Breakthrough’s BT-Reveal™ Early Pancreatic Cancer Test.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
